Clinical Trial Update: Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial investigates whether immunophenotyping peripheral blood mononuclear cells can early predict response to immunotherapy in hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Liver Cancer, Adult | Status: RECRUITING